Table 1.
Resistance of Staphylococcus aureus isolates to different antibiotics throughout the six-year study period.
| Resistance | Total (n = 2096) | Period 1 (n = 612) | Period 2 (n = 477) | Period 3 (n = 293) | Period 4 (n = 714) |
|---|---|---|---|---|---|
| Any | 1845 (88.0%) | 534 (87.3%) | 423 (88.7%) | 256 (87.4%) | 632 (88.5%) |
| PEN G | 1507 (71.9%) | 429 (70.1%) | 314 (65.8%) | 225 (76.8%) | 539 (75.5%) |
| FOX | 440 (21.0%) | 125 (20.4%) | 138 (28.9%) | 4 (1.4%) | 173 (24.2%) |
| CMN | 379 (18.1%) | 109 (17.8%) | 81 (17.0%) | 52 (17.7%) | 137 (19.2%) |
| ERY | 718 (34.3%) | 194 (31.7%) | 183 (38.4%) | 89 (30.4%) | 252 (35.3%) |
| FUS | 480 (22.9%) | 126 (20.6%) | 132 (27.7%) | 72 (24.6%) | 150 (21.0%) |
| GEN | 8 (0.4%) | 1 (0.2%) | 7 (1.5%) | 0 | 0 |
| MNO | 13 (0.6%) | 2 (0.3%) | 6 (1.3%) | 3 (1.0%) | 2 (0.3%) |
| MUP | 266 (12.7%) | 80 (13.1%) | 64 (13.4%) | 29 (9.9%) | 93 (13.0%) |
| RIF | 25 (1.2%) | 4 (0.7%) | 12 (2.5%) | 4 (1.4%) | 5 (0.7%) |
| SXT | 96 (4.6%) | 32 (5.2%) | 24 (5.0%) | 4 (1.4%) | 36 (5.0%) |
| TEC | 22 (1.0%) | 2 (0.3%) | 14 (2.9%) | 4 (1.4%) | 2 (0.3%) |
| TET | 359 (17.1%) | 99 (16.2%) | 79 (16.6%) | 53 (18.1%) | 128 (17.9%) |
No resistant isolates could be found in vancomycin PEN G: Benzylpenicillin, FOX: Cefoxitin, CMN: Clindamycin, ERY: Erythromycin, FUS: Fusidic acid, GEN: Gentamycin, MNO: Minocycline, MUP: Mupirocin, RIF: Rifampicin, SXT: Trimethoprim-Sulfamethoxazole, TEC: Teicoplanin, TET: Tetracycline.